

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.76668710 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.58317170 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.55491824 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.54174075 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.24601788 |
| 6 | histone H3-K36 demethylation (GO:0070544) | 3.99562522 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 3.97304755 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.93007859 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 3.80564627 |
| 10 | vocalization behavior (GO:0071625) | 3.75787722 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.74075027 |
| 12 | glutamate secretion (GO:0014047) | 3.69327744 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.69045645 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.60890047 |
| 15 | dendritic spine morphogenesis (GO:0060997) | 3.59871146 |
| 16 | regulation of ARF protein signal transduction (GO:0032012) | 3.46620547 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.46407759 |
| 18 | vesicle transport along microtubule (GO:0047496) | 3.44191110 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.39768548 |
| 20 | protein localization to synapse (GO:0035418) | 3.39149299 |
| 21 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.37361421 |
| 22 | exploration behavior (GO:0035640) | 3.36922643 |
| 23 | regulation of cholesterol homeostasis (GO:2000188) | 3.36758404 |
| 24 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.36449489 |
| 25 | neurotransmitter secretion (GO:0007269) | 3.35591608 |
| 26 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.32960018 |
| 27 | proline transport (GO:0015824) | 3.31687579 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.30101805 |
| 29 | mannose metabolic process (GO:0006013) | 3.29186662 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.28232394 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.27654225 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.25916721 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25874084 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.25837375 |
| 35 | prepulse inhibition (GO:0060134) | 3.19396024 |
| 36 | protein targeting to Golgi (GO:0000042) | 3.18634532 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.18499126 |
| 38 | long-term memory (GO:0007616) | 3.17291049 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13473887 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.13473887 |
| 41 | regulation of synapse structural plasticity (GO:0051823) | 3.12228486 |
| 42 | detection of calcium ion (GO:0005513) | 3.07389584 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.03386449 |
| 44 | establishment of protein localization to Golgi (GO:0072600) | 3.02562576 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 3.01578943 |
| 46 | negative regulation of fatty acid transport (GO:2000192) | 3.01359989 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.01087459 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99914688 |
| 49 | regulation of ARF GTPase activity (GO:0032312) | 2.98868074 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 2.98128672 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 2.98124400 |
| 52 | protein localization to endosome (GO:0036010) | 2.92829972 |
| 53 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.92648154 |
| 54 | innervation (GO:0060384) | 2.92580555 |
| 55 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.90245751 |
| 56 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89149391 |
| 57 | neuron recognition (GO:0008038) | 2.86485835 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86339758 |
| 59 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.85722750 |
| 60 | dendrite morphogenesis (GO:0048813) | 2.83506175 |
| 61 | axonal fasciculation (GO:0007413) | 2.83222287 |
| 62 | neuromuscular process controlling balance (GO:0050885) | 2.83051994 |
| 63 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.82905417 |
| 64 | membrane depolarization during action potential (GO:0086010) | 2.82076384 |
| 65 | sodium ion export (GO:0071436) | 2.81608604 |
| 66 | striatum development (GO:0021756) | 2.79614259 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.79502418 |
| 68 | long-term synaptic potentiation (GO:0060291) | 2.79355479 |
| 69 | establishment of nucleus localization (GO:0040023) | 2.78763926 |
| 70 | regulation of synaptic plasticity (GO:0048167) | 2.78012696 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76813544 |
| 72 | synaptic vesicle endocytosis (GO:0048488) | 2.76048984 |
| 73 | suckling behavior (GO:0001967) | 2.75746326 |
| 74 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.74970186 |
| 75 | mating behavior (GO:0007617) | 2.72575387 |
| 76 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.72301844 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71933451 |
| 78 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.70088627 |
| 79 | neurotransmitter transport (GO:0006836) | 2.69777627 |
| 80 | dendritic spine organization (GO:0097061) | 2.67688092 |
| 81 | transmission of nerve impulse (GO:0019226) | 2.67502304 |
| 82 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.67399784 |
| 83 | chemosensory behavior (GO:0007635) | 2.67251813 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.66980432 |
| 85 | organelle transport along microtubule (GO:0072384) | 2.66434184 |
| 86 | histone H3-K9 demethylation (GO:0033169) | 2.66262004 |
| 87 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.66228153 |
| 88 | histone lysine demethylation (GO:0070076) | 2.65182594 |
| 89 | gamma-aminobutyric acid transport (GO:0015812) | 2.64935122 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 2.64435246 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.64260272 |
| 92 | auditory behavior (GO:0031223) | 2.64221855 |
| 93 | nerve growth factor signaling pathway (GO:0038180) | 2.63169822 |
| 94 | protein-lipid complex assembly (GO:0065005) | 2.61177309 |
| 95 | regulation of vesicle fusion (GO:0031338) | 2.61162467 |
| 96 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.59894740 |
| 97 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59857735 |
| 98 | positive regulation of membrane potential (GO:0045838) | 2.59530399 |
| 99 | response to auditory stimulus (GO:0010996) | 2.59498805 |
| 100 | positive regulation of Rap GTPase activity (GO:0032854) | 2.59193653 |
| 101 | response to histamine (GO:0034776) | 2.57799358 |
| 102 | positive regulation of vesicle fusion (GO:0031340) | 2.56747363 |
| 103 | membrane depolarization (GO:0051899) | 2.56157313 |
| 104 | histone demethylation (GO:0016577) | 2.55501930 |
| 105 | behavioral defense response (GO:0002209) | 2.55183231 |
| 106 | behavioral fear response (GO:0001662) | 2.55183231 |
| 107 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.55147393 |
| 108 | regulation of neurotransmitter secretion (GO:0046928) | 2.52668658 |
| 109 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.52602508 |
| 110 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.51885112 |
| 111 | cell communication by electrical coupling (GO:0010644) | 2.50566384 |
| 112 | long term synaptic depression (GO:0060292) | 2.48743405 |
| 113 | dopamine receptor signaling pathway (GO:0007212) | 2.47502613 |
| 114 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.46932041 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.46763362 |
| 116 | synapse assembly (GO:0007416) | 2.46124683 |
| 117 | potassium ion import (GO:0010107) | 2.45668584 |
| 118 | calcium ion-dependent exocytosis (GO:0017156) | 2.44853612 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.42654787 |
| 120 | L-amino acid import (GO:0043092) | 2.42354723 |
| 121 | positive regulation of synapse maturation (GO:0090129) | 2.41870335 |
| 122 | diacylglycerol metabolic process (GO:0046339) | 2.40666266 |
| 123 | signal complex assembly (GO:0007172) | 2.39090084 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.33795285 |
| 125 | macroautophagy (GO:0016236) | 2.33385761 |
| 126 | embryonic process involved in female pregnancy (GO:0060136) | 2.31739364 |
| 127 | cell-cell junction maintenance (GO:0045217) | 2.31688538 |
| 128 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30365333 |
| 129 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28795899 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 2.26400566 |
| 131 | regulation of cellular amide metabolic process (GO:0034248) | 2.25415596 |
| 132 | regulation of extracellular matrix disassembly (GO:0010715) | 2.24777486 |
| 133 | cerebellar granule cell differentiation (GO:0021707) | 2.22305433 |
| 134 | amino acid import (GO:0043090) | 2.22287467 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21221400 |
| 136 | regulation of histone H3-K27 methylation (GO:0061085) | 2.21076496 |
| 137 | regulation of apoptotic cell clearance (GO:2000425) | 2.21015296 |
| 138 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.16547033 |
| 139 | protein dealkylation (GO:0008214) | 2.16331229 |
| 140 | protein demethylation (GO:0006482) | 2.16331229 |
| 141 | positive regulation of protein dephosphorylation (GO:0035307) | 2.15337955 |
| 142 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.15212490 |
| 143 | hypotonic response (GO:0006971) | 2.14830502 |
| 144 | * focal adhesion assembly (GO:0048041) | 2.14056897 |
| 145 | * cell-substrate adherens junction assembly (GO:0007045) | 2.14056897 |
| 146 | receptor recycling (GO:0001881) | 2.13333801 |
| 147 | regulation of extracellular matrix organization (GO:1903053) | 2.11108597 |
| 148 | regulation of beta-amyloid formation (GO:1902003) | 2.10403061 |
| 149 | regulation of Rap GTPase activity (GO:0032317) | 2.10121213 |
| 150 | detection of molecule of bacterial origin (GO:0032490) | 2.08906617 |
| 151 | * adherens junction assembly (GO:0034333) | 2.08404876 |
| 152 | receptor catabolic process (GO:0032801) | 2.07269684 |
| 153 | * peptidyl-threonine modification (GO:0018210) | 2.05584572 |
| 154 | * peptidyl-threonine phosphorylation (GO:0018107) | 2.05067087 |
| 155 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.02522158 |
| 156 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.02032676 |
| 157 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.01356997 |
| 158 | activation of Rac GTPase activity (GO:0032863) | 2.01344583 |
| 159 | cell volume homeostasis (GO:0006884) | 2.00883414 |
| 160 | lipoprotein transport (GO:0042953) | 2.00777014 |
| 161 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.00734713 |
| 162 | protein carboxylation (GO:0018214) | 1.99666072 |
| 163 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.99666072 |
| 164 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 1.99449094 |
| 165 | negative regulation of myotube differentiation (GO:0010832) | 1.99368076 |
| 166 | cellular extravasation (GO:0045123) | 1.98630262 |
| 167 | cortical actin cytoskeleton organization (GO:0030866) | 1.98371258 |
| 168 | regulation of cholesterol biosynthetic process (GO:0045540) | 1.96178888 |
| 169 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.95915566 |
| 170 | * negative regulation of toll-like receptor signaling pathway (GO:0034122) | 1.95444642 |
| 171 | cellular sodium ion homeostasis (GO:0006883) | 1.94931224 |
| 172 | barbed-end actin filament capping (GO:0051016) | 1.93313649 |
| 173 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.93214838 |
| 174 | negative regulation of lipid transport (GO:0032369) | 1.92829681 |
| 175 | dicarboxylic acid biosynthetic process (GO:0043650) | 1.90708601 |
| 176 | cholesterol efflux (GO:0033344) | 1.88768045 |
| 177 | cell junction maintenance (GO:0034331) | 1.88638205 |
| 178 | cellular response to monoamine stimulus (GO:0071868) | 1.87778175 |
| 179 | cellular response to catecholamine stimulus (GO:0071870) | 1.87778175 |
| 180 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.87735578 |
| 181 | positive regulation of CREB transcription factor activity (GO:0032793) | 1.87438160 |
| 182 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.87325636 |
| 183 | low-density lipoprotein particle clearance (GO:0034383) | 1.87213747 |
| 184 | stress fiber assembly (GO:0043149) | 1.87060481 |
| 185 | detection of other organism (GO:0098543) | 1.86969724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.12925233 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93654113 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79280455 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55368865 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.53378970 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.42112393 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.38213200 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31682858 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24342563 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17228014 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17055005 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.16403528 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12728572 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11594836 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.10288303 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08316004 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07871135 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06559209 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05886391 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04743432 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.00105577 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98988204 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98933100 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87484314 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.85582536 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83520818 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83098494 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83098494 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81260822 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79360405 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79260133 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78270299 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.77512390 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76978322 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76746900 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70604649 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.66912515 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63780478 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63270990 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.60382524 |
| 41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.60317293 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59893981 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59206351 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58540061 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58349474 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56596278 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56417139 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56358457 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55818702 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55031985 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54095652 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.53982932 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52902496 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50554465 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50086415 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49704111 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49622275 |
| 58 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49584926 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48957173 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48795556 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47631829 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46918006 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.45706976 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45696942 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.45686054 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45417223 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.44824835 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44318693 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44010528 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43465805 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42974151 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42773388 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42143673 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41087057 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40987495 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39694488 |
| 77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36567384 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36142375 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35043140 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34608761 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34380254 |
| 82 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33926399 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33447540 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33376876 |
| 85 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33315124 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33164185 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33121740 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32608100 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31981063 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31940892 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30603459 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30184321 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29604988 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29498758 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29495102 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29132633 |
| 97 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.28731579 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28480487 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28290451 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28249684 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.28226473 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28080386 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27613280 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27227490 |
| 105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26443706 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25776034 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24848674 |
| 108 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24232571 |
| 109 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23882872 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23599343 |
| 111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22790178 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22173762 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22138984 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.21765158 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21669826 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21609687 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20324382 |
| 118 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18771268 |
| 119 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.18048585 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17832608 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15869269 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15702726 |
| 123 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14078232 |
| 124 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13992470 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13683183 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 1.12627717 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12045436 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11921166 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11782744 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11207489 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09914933 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08947374 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08677063 |
| 134 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08450590 |
| 135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08229787 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08167501 |
| 137 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08059104 |
| 138 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07654892 |
| 139 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07654892 |
| 140 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07604116 |
| 141 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07604116 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07301333 |
| 143 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06736347 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 1.06228336 |
| 145 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05767989 |
| 146 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04945255 |
| 147 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04752885 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04546756 |
| 149 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.04516582 |
| 150 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04177018 |
| 151 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03968764 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02418985 |
| 153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02160750 |
| 154 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01589866 |
| 155 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01452366 |
| 156 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01108695 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00624531 |
| 158 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00408459 |
| 159 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00342971 |
| 160 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99164258 |
| 161 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99127977 |
| 162 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99104691 |
| 163 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98568823 |
| 164 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98128279 |
| 165 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97997054 |
| 166 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97791364 |
| 167 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97696899 |
| 168 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97642090 |
| 169 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97605267 |
| 170 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96954131 |
| 171 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96481152 |
| 172 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96224266 |
| 173 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96161528 |
| 174 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94917673 |
| 175 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94295402 |
| 176 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93671850 |
| 177 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93567179 |
| 178 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93166391 |
| 179 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92410050 |
| 180 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91504173 |
| 181 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91251245 |
| 182 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91233475 |
| 183 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.90024886 |
| 184 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.89887067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.97394560 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.73789993 |
| 3 | MP0004270_analgesia | 3.72697367 |
| 4 | MP0003880_abnormal_central_pattern | 3.71528595 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.38872425 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.23837789 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.13296036 |
| 8 | MP0005451_abnormal_body_composition | 3.11740977 |
| 9 | MP0009745_abnormal_behavioral_response | 2.95188312 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.87079476 |
| 11 | MP0002822_catalepsy | 2.86050905 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.81322630 |
| 13 | MP0009046_muscle_twitch | 2.71866761 |
| 14 | MP0002064_seizures | 2.59192081 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.55747008 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.54175460 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.43593243 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.38966089 |
| 19 | MP0009840_abnormal_foam_cell | 2.32665295 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.31552674 |
| 21 | MP0001486_abnormal_startle_reflex | 2.26194990 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.21885189 |
| 23 | MP0003787_abnormal_imprinting | 2.11321208 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.10796258 |
| 25 | MP0002272_abnormal_nervous_system | 2.07900020 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.03362021 |
| 27 | MP0003091_abnormal_cell_migration | 1.98843281 |
| 28 | MP0003303_peritoneal_inflammation | 1.95776595 |
| 29 | MP0005360_urolithiasis | 1.93762272 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.93680532 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.83018931 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.81261503 |
| 33 | MP0000566_synostosis | 1.80121045 |
| 34 | MP0004924_abnormal_behavior | 1.78678103 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.78678103 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.77072357 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.76881948 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.75944834 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.75856841 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.74865755 |
| 41 | MP0005423_abnormal_somatic_nervous | 1.73039922 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.71954585 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.70729900 |
| 44 | * MP0004811_abnormal_neuron_physiology | 1.69379302 |
| 45 | MP0001984_abnormal_olfaction | 1.67246956 |
| 46 | MP0002184_abnormal_innervation | 1.66598214 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.65420528 |
| 48 | MP0001970_abnormal_pain_threshold | 1.62715756 |
| 49 | MP0000778_abnormal_nervous_system | 1.62003416 |
| 50 | MP0008569_lethality_at_weaning | 1.61745236 |
| 51 | MP0003436_decreased_susceptibility_to | 1.58601886 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.58594470 |
| 53 | MP0005365_abnormal_bile_salt | 1.56859095 |
| 54 | MP0003045_fibrosis | 1.53930982 |
| 55 | MP0004858_abnormal_nervous_system | 1.53854641 |
| 56 | MP0002736_abnormal_nociception_after | 1.50223982 |
| 57 | MP0004381_abnormal_hair_follicle | 1.50020524 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.49159104 |
| 59 | MP0003868_abnormal_feces_composition | 1.48402842 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.48350559 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 1.48345312 |
| 62 | MP0004947_skin_inflammation | 1.40483672 |
| 63 | MP0003690_abnormal_glial_cell | 1.39319099 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.38510738 |
| 65 | MP0000955_abnormal_spinal_cord | 1.36527406 |
| 66 | MP0003633_abnormal_nervous_system | 1.35385546 |
| 67 | MP0008260_abnormal_autophagy | 1.35384565 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.34917879 |
| 69 | MP0001849_ear_inflammation | 1.32871519 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.30174860 |
| 71 | MP0005409_darkened_coat_color | 1.28987163 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.27542672 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.27311538 |
| 74 | MP0000604_amyloidosis | 1.24451521 |
| 75 | MP0002132_abnormal_respiratory_system | 1.22682906 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.21356125 |
| 77 | MP0001958_emphysema | 1.20580666 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.19944962 |
| 79 | MP0003122_maternal_imprinting | 1.19311408 |
| 80 | MP0002009_preneoplasia | 1.19006410 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.18199859 |
| 82 | MP0000685_abnormal_immune_system | 1.17648026 |
| 83 | MP0004885_abnormal_endolymph | 1.17245960 |
| 84 | MP0003329_amyloid_beta_deposits | 1.16922742 |
| 85 | MP0000920_abnormal_myelination | 1.16184644 |
| 86 | MP0001502_abnormal_circadian_rhythm | 1.14482631 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.14433308 |
| 88 | MP0003300_gastrointestinal_ulcer | 1.13180242 |
| 89 | MP0001529_abnormal_vocalization | 1.12331089 |
| 90 | MP0000747_muscle_weakness | 1.09245464 |
| 91 | * MP0002152_abnormal_brain_morphology | 1.08754532 |
| 92 | MP0003631_nervous_system_phenotype | 1.08612927 |
| 93 | MP0000678_abnormal_parathyroid_gland | 1.07687966 |
| 94 | * MP0005646_abnormal_pituitary_gland | 1.06834566 |
| 95 | MP0005535_abnormal_body_temperature | 1.06814087 |
| 96 | MP0000003_abnormal_adipose_tissue | 1.05993364 |
| 97 | MP0002796_impaired_skin_barrier | 1.04296119 |
| 98 | MP0001348_abnormal_lacrimal_gland | 1.03311357 |
| 99 | MP0003879_abnormal_hair_cell | 1.00528230 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.99449940 |
| 101 | MP0003123_paternal_imprinting | 0.99198632 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.99064622 |
| 103 | MP0008004_abnormal_stomach_pH | 0.98571871 |
| 104 | MP0003866_abnormal_defecation | 0.98393766 |
| 105 | MP0001177_atelectasis | 0.98319906 |
| 106 | MP0002229_neurodegeneration | 0.96350811 |
| 107 | MP0005187_abnormal_penis_morphology | 0.95856949 |
| 108 | MP0009115_abnormal_fat_cell | 0.95693792 |
| 109 | MP0004130_abnormal_muscle_cell | 0.95047888 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.92854624 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.91920361 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.91640790 |
| 113 | MP0003828_pulmonary_edema | 0.91479933 |
| 114 | MP0000858_altered_metastatic_potential | 0.90634801 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.89815765 |
| 116 | MP0001188_hyperpigmentation | 0.89304204 |
| 117 | MP0001664_abnormal_digestion | 0.88205211 |
| 118 | MP0005621_abnormal_cell_physiology | 0.87531249 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.86585191 |
| 120 | MP0006138_congestive_heart_failure | 0.86366137 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.85960982 |
| 122 | MP0003121_genomic_imprinting | 0.85605272 |
| 123 | MP0002971_abnormal_brown_adipose | 0.83960815 |
| 124 | MP0004085_abnormal_heartbeat | 0.83851871 |
| 125 | MP0002419_abnormal_innate_immunity | 0.83761324 |
| 126 | MP0004233_abnormal_muscle_weight | 0.82836652 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.82723886 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.82541916 |
| 129 | * MP0002069_abnormal_eating/drinking_beha | 0.82460521 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.81356445 |
| 131 | * MP0001944_abnormal_pancreas_morphology | 0.80280101 |
| 132 | MP0004510_myositis | 0.80152183 |
| 133 | * MP0002693_abnormal_pancreas_physiology | 0.80129729 |
| 134 | MP0000609_abnormal_liver_physiology | 0.80040114 |
| 135 | MP0002168_other_aberrant_phenotype | 0.79778167 |
| 136 | * MP0000631_abnormal_neuroendocrine_gland | 0.79659075 |
| 137 | MP0006072_abnormal_retinal_apoptosis | 0.79474462 |
| 138 | MP0003283_abnormal_digestive_organ | 0.78714228 |
| 139 | MP0004883_abnormal_blood_vessel | 0.78670736 |
| 140 | MP0002249_abnormal_larynx_morphology | 0.77195610 |
| 141 | MP0005166_decreased_susceptibility_to | 0.76569440 |
| 142 | MP0008874_decreased_physiological_sensi | 0.76073728 |
| 143 | * MP0010630_abnormal_cardiac_muscle | 0.75536600 |
| 144 | MP0003075_altered_response_to | 0.75499100 |
| 145 | MP0002090_abnormal_vision | 0.74070527 |
| 146 | MP0003632_abnormal_nervous_system | 0.73537225 |
| 147 | MP0005310_abnormal_salivary_gland | 0.72463647 |
| 148 | MP0005025_abnormal_response_to | 0.72188645 |
| 149 | MP0003634_abnormal_glial_cell | 0.71419356 |
| 150 | MP0002098_abnormal_vibrissa_morphology | 0.70439438 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.70240081 |
| 152 | MP0002876_abnormal_thyroid_physiology | 0.69665620 |
| 153 | MP0004215_abnormal_myocardial_fiber | 0.69663542 |
| 154 | MP0000015_abnormal_ear_pigmentation | 0.69575484 |
| 155 | MP0000733_abnormal_muscle_development | 0.68907864 |
| 156 | MP0005085_abnormal_gallbladder_physiolo | 0.68879990 |
| 157 | MP0004043_abnormal_pH_regulation | 0.68514141 |
| 158 | MP0004742_abnormal_vestibular_system | 0.68237893 |
| 159 | MP0004484_altered_response_of | 0.67959641 |
| 160 | MP0001790_abnormal_immune_system | 0.67761170 |
| 161 | MP0005387_immune_system_phenotype | 0.67761170 |
| 162 | MP0003183_abnormal_peptide_metabolism | 0.67573946 |
| 163 | MP0005253_abnormal_eye_physiology | 0.66388549 |
| 164 | * MP0002078_abnormal_glucose_homeostasis | 0.65348302 |
| 165 | MP0005410_abnormal_fertilization | 0.63833748 |
| 166 | * MP0003861_abnormal_nervous_system | 0.63391884 |
| 167 | MP0004145_abnormal_muscle_electrophysio | 0.59904618 |
| 168 | MP0001943_abnormal_respiration | 0.59474835 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.59460208 |
| 170 | MP0008877_abnormal_DNA_methylation | 0.59183715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.35827222 |
| 2 | Focal seizures (HP:0007359) | 4.62101911 |
| 3 | Visual hallucinations (HP:0002367) | 4.25172993 |
| 4 | Myokymia (HP:0002411) | 4.23495959 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.74925435 |
| 6 | Febrile seizures (HP:0002373) | 3.55273467 |
| 7 | Obstructive sleep apnea (HP:0002870) | 3.47133416 |
| 8 | Atonic seizures (HP:0010819) | 3.31171408 |
| 9 | Action tremor (HP:0002345) | 3.29861689 |
| 10 | Truncal ataxia (HP:0002078) | 3.24157512 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.20559963 |
| 12 | Macroorchidism (HP:0000053) | 3.15577878 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.14394983 |
| 14 | Absence seizures (HP:0002121) | 3.12911142 |
| 15 | Papilledema (HP:0001085) | 3.04267863 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.03577415 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.01421892 |
| 18 | Excessive salivation (HP:0003781) | 3.00087058 |
| 19 | Drooling (HP:0002307) | 3.00087058 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.87099049 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.84597852 |
| 22 | Dialeptic seizures (HP:0011146) | 2.83517519 |
| 23 | Impaired smooth pursuit (HP:0007772) | 2.80483892 |
| 24 | Flat acetabular roof (HP:0003180) | 2.78629759 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 2.78569449 |
| 26 | Dysdiadochokinesis (HP:0002075) | 2.68951422 |
| 27 | Dysmetric saccades (HP:0000641) | 2.60950942 |
| 28 | Ankyloglossia (HP:0010296) | 2.59724975 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.59219366 |
| 30 | Insidious onset (HP:0003587) | 2.58863645 |
| 31 | Termporal pattern (HP:0011008) | 2.58863645 |
| 32 | Depression (HP:0000716) | 2.53933022 |
| 33 | Broad-based gait (HP:0002136) | 2.53576870 |
| 34 | Resting tremor (HP:0002322) | 2.51222804 |
| 35 | Impaired social interactions (HP:0000735) | 2.48795652 |
| 36 | Abnormal social behavior (HP:0012433) | 2.48795652 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.46984963 |
| 38 | Cerebral aneurysm (HP:0004944) | 2.45530347 |
| 39 | Genetic anticipation (HP:0003743) | 2.45330507 |
| 40 | Poor eye contact (HP:0000817) | 2.43288603 |
| 41 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40040866 |
| 42 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.39330296 |
| 43 | Postural instability (HP:0002172) | 2.38262433 |
| 44 | Urinary urgency (HP:0000012) | 2.34565195 |
| 45 | Mitral stenosis (HP:0001718) | 2.34180388 |
| 46 | Dysmetria (HP:0001310) | 2.32990570 |
| 47 | Ankle clonus (HP:0011448) | 2.31898881 |
| 48 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29572176 |
| 49 | Broad face (HP:0000283) | 2.22514346 |
| 50 | Aqueductal stenosis (HP:0002410) | 2.21916202 |
| 51 | Absent speech (HP:0001344) | 2.20758813 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.18611867 |
| 53 | Abnormality of oral frenula (HP:0000190) | 2.18578538 |
| 54 | Hyperventilation (HP:0002883) | 2.17536172 |
| 55 | Thin bony cortex (HP:0002753) | 2.16038287 |
| 56 | Anxiety (HP:0000739) | 2.13825278 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.13298160 |
| 58 | Obsessive-compulsive behavior (HP:0000722) | 2.12682585 |
| 59 | Ulnar bowing (HP:0003031) | 2.12528218 |
| 60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.10338959 |
| 61 | Papillary thyroid carcinoma (HP:0002895) | 2.09925581 |
| 62 | Hyperacusis (HP:0010780) | 2.09675237 |
| 63 | Amblyopia (HP:0000646) | 2.09549175 |
| 64 | Germ cell neoplasia (HP:0100728) | 2.08030004 |
| 65 | Asymmetry of the thorax (HP:0001555) | 2.07707780 |
| 66 | Truncal obesity (HP:0001956) | 2.07330976 |
| 67 | Scanning speech (HP:0002168) | 2.06365287 |
| 68 | Agitation (HP:0000713) | 2.05735881 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03846140 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.03471910 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.02667728 |
| 72 | Aneurysm (HP:0002617) | 2.02476707 |
| 73 | Pointed chin (HP:0000307) | 2.02458648 |
| 74 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01773237 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.01346442 |
| 76 | Stereotypic behavior (HP:0000733) | 2.00829732 |
| 77 | Heterotopia (HP:0002282) | 2.00441532 |
| 78 | Inappropriate behavior (HP:0000719) | 1.99646918 |
| 79 | Hemiparesis (HP:0001269) | 1.99579915 |
| 80 | Arterial tortuosity (HP:0005116) | 1.99092400 |
| 81 | Progressive sensorineural hearing impairment (HP:0000408) | 1.98397304 |
| 82 | Abnormality of salivation (HP:0100755) | 1.97956114 |
| 83 | Abnormality of the thoracic spine (HP:0100711) | 1.97336878 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 1.97307482 |
| 85 | Spastic gait (HP:0002064) | 1.97264180 |
| 86 | Joint hemorrhage (HP:0005261) | 1.95105933 |
| 87 | Hyporeflexia of lower limbs (HP:0002600) | 1.94021185 |
| 88 | Malnutrition (HP:0004395) | 1.93642879 |
| 89 | Intention tremor (HP:0002080) | 1.93060511 |
| 90 | Blue irides (HP:0000635) | 1.92795270 |
| 91 | Impaired vibratory sensation (HP:0002495) | 1.92696306 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92578426 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.89979687 |
| 94 | Menstrual irregularities (HP:0000858) | 1.89852005 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89538157 |
| 96 | Mucopolysacchariduria (HP:0008155) | 1.89538157 |
| 97 | Hypercortisolism (HP:0001578) | 1.89103706 |
| 98 | Exercise-induced myalgia (HP:0003738) | 1.88268560 |
| 99 | Generalized hypopigmentation of hair (HP:0011358) | 1.88205747 |
| 100 | Exotropia (HP:0000577) | 1.86059306 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.85842970 |
| 102 | Abnormality of the common coagulation pathway (HP:0010990) | 1.84762332 |
| 103 | Lower limb muscle weakness (HP:0007340) | 1.83443595 |
| 104 | Absent/shortened dynein arms (HP:0200106) | 1.82818015 |
| 105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.82818015 |
| 106 | Volvulus (HP:0002580) | 1.81460849 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 1.80315500 |
| 108 | Dislocated radial head (HP:0003083) | 1.78850771 |
| 109 | Abnormality of the corticospinal tract (HP:0002492) | 1.78387801 |
| 110 | Onion bulb formation (HP:0003383) | 1.78242041 |
| 111 | Open mouth (HP:0000194) | 1.78158830 |
| 112 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76574519 |
| 113 | Colitis (HP:0002583) | 1.75651893 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.75140396 |
| 115 | Hypercholesterolemia (HP:0003124) | 1.75077095 |
| 116 | Failure to thrive in infancy (HP:0001531) | 1.74524968 |
| 117 | Widely spaced teeth (HP:0000687) | 1.74417591 |
| 118 | Spinal cord lesions (HP:0100561) | 1.73583438 |
| 119 | Syringomyelia (HP:0003396) | 1.73583438 |
| 120 | Abnormal eating behavior (HP:0100738) | 1.72807069 |
| 121 | Vascular tortuosity (HP:0004948) | 1.71657998 |
| 122 | Bradykinesia (HP:0002067) | 1.71518756 |
| 123 | Neoplasm of the heart (HP:0100544) | 1.70737700 |
| 124 | Thyroid carcinoma (HP:0002890) | 1.69421338 |
| 125 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69019791 |
| 126 | Abnormality of macrophages (HP:0004311) | 1.68974092 |
| 127 | Slow saccadic eye movements (HP:0000514) | 1.68518950 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 1.67757745 |
| 129 | Upper limb amyotrophy (HP:0009129) | 1.67757745 |
| 130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.67754809 |
| 131 | Megalencephaly (HP:0001355) | 1.67537061 |
| 132 | Abnormality of the radial head (HP:0003995) | 1.66757998 |
| 133 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66599901 |
| 134 | Hyperparathyroidism (HP:0000843) | 1.65970136 |
| 135 | Progressive hearing impairment (HP:0001730) | 1.64750420 |
| 136 | Decreased motor nerve conduction velocity (HP:0003431) | 1.64606925 |
| 137 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.64579773 |
| 138 | Deeply set eye (HP:0000490) | 1.64571266 |
| 139 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.64505648 |
| 140 | Abnormality of carpal bone ossification (HP:0006257) | 1.64398114 |
| 141 | Neurofibrillary tangles (HP:0002185) | 1.64322305 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64294203 |
| 143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64294203 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64294203 |
| 145 | Ventricular fibrillation (HP:0001663) | 1.64179236 |
| 146 | Absent frontal sinuses (HP:0002688) | 1.64079451 |
| 147 | Hemiplegia (HP:0002301) | 1.63810071 |
| 148 | Central scotoma (HP:0000603) | 1.63618664 |
| 149 | Subacute progressive viral hepatitis (HP:0006572) | 1.63367232 |
| 150 | Deep palmar crease (HP:0006191) | 1.63000280 |
| 151 | Thoracic kyphosis (HP:0002942) | 1.62051895 |
| 152 | Status epilepticus (HP:0002133) | 1.61290044 |
| 153 | Bronchomalacia (HP:0002780) | 1.61253848 |
| 154 | Increased variability in muscle fiber diameter (HP:0003557) | 1.61193318 |
| 155 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.61189186 |
| 156 | Coarse hair (HP:0002208) | 1.61062584 |
| 157 | Protruding tongue (HP:0010808) | 1.60701997 |
| 158 | Progressive inability to walk (HP:0002505) | 1.60500248 |
| 159 | Bundle branch block (HP:0011710) | 1.60140515 |
| 160 | Increased connective tissue (HP:0009025) | 1.59999208 |
| 161 | Abnormality of the columella (HP:0009929) | 1.59931898 |
| 162 | Mutism (HP:0002300) | 1.57914287 |
| 163 | Abnormal ossification of hand bones (HP:0005921) | 1.57748899 |
| 164 | Gingival bleeding (HP:0000225) | 1.57339385 |
| 165 | Gingivitis (HP:0000230) | 1.55626300 |
| 166 | Akinesia (HP:0002304) | 1.55148877 |
| 167 | Foot dorsiflexor weakness (HP:0009027) | 1.53926441 |
| 168 | Cubitus valgus (HP:0002967) | 1.52565754 |
| 169 | Vertebral compression fractures (HP:0002953) | 1.51787547 |
| 170 | Vascular calcification (HP:0004934) | 1.51394134 |
| 171 | Persistence of primary teeth (HP:0006335) | 1.51387067 |
| 172 | Mitral valve prolapse (HP:0001634) | 1.51020520 |
| 173 | Prolonged partial thromboplastin time (HP:0003645) | 1.50655386 |
| 174 | Increased cerebral lipofuscin (HP:0011813) | 1.50018214 |
| 175 | Cellulitis (HP:0100658) | 1.48828315 |
| 176 | Aortic aneurysm (HP:0004942) | 1.48685915 |
| 177 | Vertebral arch anomaly (HP:0008438) | 1.48567460 |
| 178 | Apathy (HP:0000741) | 1.47055809 |
| 179 | Polycythemia (HP:0001901) | 1.46953700 |
| 180 | Right ventricular cardiomyopathy (HP:0011663) | 1.45903727 |
| 181 | Abnormality of the lumbar spine (HP:0100712) | 1.45520017 |
| 182 | Complement deficiency (HP:0004431) | 1.44969231 |
| 183 | Glomerulonephritis (HP:0000099) | 1.44372151 |
| 184 | Long palpebral fissure (HP:0000637) | 1.43311031 |
| 185 | Xanthomatosis (HP:0000991) | 1.43270496 |
| 186 | Nasal polyposis (HP:0100582) | 1.42807749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.93901706 |
| 2 | NTRK3 | 3.90095584 |
| 3 | MAP3K9 | 3.31684266 |
| 4 | PRKD3 | 2.59445017 |
| 5 | FGFR4 | 2.47093276 |
| 6 | MAP3K4 | 2.36596338 |
| 7 | EEF2K | 2.27128387 |
| 8 | KSR2 | 2.21301683 |
| 9 | RIPK4 | 2.18723323 |
| 10 | MAP3K2 | 2.05208238 |
| 11 | ERN1 | 2.04063933 |
| 12 | NTRK2 | 1.93461198 |
| 13 | SIK1 | 1.92433667 |
| 14 | MINK1 | 1.87067146 |
| 15 | KSR1 | 1.83261926 |
| 16 | PAK6 | 1.83099892 |
| 17 | MARK1 | 1.81680603 |
| 18 | NTRK1 | 1.69846805 |
| 19 | SMG1 | 1.62372781 |
| 20 | FGFR2 | 1.60499890 |
| 21 | SIK2 | 1.54033553 |
| 22 | CAMKK1 | 1.45992494 |
| 23 | PKN2 | 1.45306368 |
| 24 | EPHB1 | 1.43548799 |
| 25 | FRK | 1.42855942 |
| 26 | STK38 | 1.41581251 |
| 27 | DAPK2 | 1.41096624 |
| 28 | CAMK1G | 1.40528090 |
| 29 | TYRO3 | 1.38718709 |
| 30 | CDK12 | 1.36159877 |
| 31 | MAP2K7 | 1.31976610 |
| 32 | PNCK | 1.31368433 |
| 33 | MAP2K3 | 1.30856867 |
| 34 | MAP3K10 | 1.28817550 |
| 35 | SGK2 | 1.28726333 |
| 36 | CDK5 | 1.28094322 |
| 37 | PRKCH | 1.26374226 |
| 38 | WNK1 | 1.25946526 |
| 39 | SGK3 | 1.24442136 |
| 40 | MAP2K4 | 1.23806272 |
| 41 | MAP3K13 | 1.23320075 |
| 42 | TAOK2 | 1.16945830 |
| 43 | LATS1 | 1.14338383 |
| 44 | DMPK | 1.12743085 |
| 45 | BMPR2 | 1.10922865 |
| 46 | * PDPK1 | 1.09965843 |
| 47 | * RET | 1.09320075 |
| 48 | FGFR3 | 1.07199358 |
| 49 | MAP3K3 | 1.06388115 |
| 50 | TYK2 | 1.05769939 |
| 51 | BLK | 1.03249538 |
| 52 | MTOR | 1.02386483 |
| 53 | STK11 | 1.00940790 |
| 54 | WNK3 | 1.00938590 |
| 55 | MAPK12 | 0.98105535 |
| 56 | FES | 0.96649105 |
| 57 | MAPK13 | 0.96608139 |
| 58 | ZAP70 | 0.94793521 |
| 59 | SGK494 | 0.93806953 |
| 60 | SGK223 | 0.93806953 |
| 61 | PLK2 | 0.93072844 |
| 62 | PRPF4B | 0.92044516 |
| 63 | SGK1 | 0.91476758 |
| 64 | RIPK1 | 0.90896462 |
| 65 | MAP4K1 | 0.89978582 |
| 66 | PAK3 | 0.88936780 |
| 67 | TTN | 0.88895463 |
| 68 | MARK2 | 0.86467261 |
| 69 | PDGFRA | 0.85953445 |
| 70 | CAMK1D | 0.84553776 |
| 71 | MAPK11 | 0.84461862 |
| 72 | NEK6 | 0.83949810 |
| 73 | PDGFRB | 0.82130317 |
| 74 | MAP3K1 | 0.80195248 |
| 75 | INSRR | 0.79152071 |
| 76 | LATS2 | 0.78790066 |
| 77 | ALK | 0.77544858 |
| 78 | RAF1 | 0.76401860 |
| 79 | IRAK2 | 0.76345314 |
| 80 | HIPK2 | 0.76250791 |
| 81 | TAOK1 | 0.75714970 |
| 82 | GRK5 | 0.72736601 |
| 83 | EPHA2 | 0.72713348 |
| 84 | SCYL2 | 0.71331125 |
| 85 | CDC42BPA | 0.71199262 |
| 86 | UHMK1 | 0.70792751 |
| 87 | PRKCG | 0.68891915 |
| 88 | MAP3K7 | 0.66423779 |
| 89 | PTK6 | 0.66290429 |
| 90 | CAMK2A | 0.66202872 |
| 91 | CSNK1G2 | 0.65423249 |
| 92 | CAMKK2 | 0.61227332 |
| 93 | PRKD2 | 0.61213868 |
| 94 | * PDK1 | 0.60414307 |
| 95 | FER | 0.59721516 |
| 96 | NEK9 | 0.59679372 |
| 97 | AKT3 | 0.59511091 |
| 98 | MARK3 | 0.58873605 |
| 99 | CAMK4 | 0.57918277 |
| 100 | MAPK10 | 0.57900382 |
| 101 | TRIB3 | 0.57838441 |
| 102 | MAP3K14 | 0.57823160 |
| 103 | PRKAA2 | 0.56232262 |
| 104 | RPS6KA3 | 0.56089487 |
| 105 | JAK2 | 0.55983218 |
| 106 | CSK | 0.55698203 |
| 107 | JAK1 | 0.55321485 |
| 108 | FGR | 0.55298322 |
| 109 | PRKAA1 | 0.54222853 |
| 110 | MAPKAPK3 | 0.53870085 |
| 111 | CSF1R | 0.53412006 |
| 112 | PINK1 | 0.53160978 |
| 113 | LMTK2 | 0.51815450 |
| 114 | DYRK1B | 0.51803269 |
| 115 | PTK2 | 0.50660674 |
| 116 | CDK9 | 0.50474788 |
| 117 | DAPK1 | 0.49130957 |
| 118 | DYRK1A | 0.47907115 |
| 119 | WNK4 | 0.47831371 |
| 120 | TNK2 | 0.47808399 |
| 121 | PHKG2 | 0.47382783 |
| 122 | PHKG1 | 0.47382783 |
| 123 | MAP3K11 | 0.47035990 |
| 124 | FYN | 0.46913941 |
| 125 | BRD4 | 0.46228979 |
| 126 | ICK | 0.45631397 |
| 127 | PTK2B | 0.45449843 |
| 128 | CDK18 | 0.44910616 |
| 129 | TRPM7 | 0.44859028 |
| 130 | PIK3CA | 0.44549216 |
| 131 | CDK15 | 0.44445482 |
| 132 | RPS6KA2 | 0.44284509 |
| 133 | STK24 | 0.44232129 |
| 134 | PRKCE | 0.43393542 |
| 135 | PDK4 | 0.43142160 |
| 136 | PDK3 | 0.43142160 |
| 137 | CAMK1 | 0.42438922 |
| 138 | CSNK1D | 0.42290558 |
| 139 | IRAK3 | 0.41850307 |
| 140 | GRK6 | 0.41818284 |
| 141 | CDK14 | 0.41708490 |
| 142 | PRKCZ | 0.41488261 |
| 143 | ARAF | 0.41289946 |
| 144 | IRAK4 | 0.40375657 |
| 145 | RPS6KC1 | 0.38896785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46562606 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45918434 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.31555873 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17449744 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14900453 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.05438678 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02167816 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.01617118 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.97386529 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97279216 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.96342490 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91867274 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91212908 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.77375228 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73979325 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73855304 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.73338789 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.70960165 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.69071980 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66006960 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64855897 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63890761 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.57967465 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48756984 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48303934 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46780919 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45043839 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.44185857 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.43974070 |
| 30 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43377526 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38824525 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37238732 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.35425113 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.34361741 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28851276 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25716357 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20359131 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19820309 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19392289 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15197862 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12494734 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.12467038 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.12191519 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09839010 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.08522537 |
| 46 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06274532 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05660232 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04928730 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04080343 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.02008807 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00822559 |
| 52 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98348622 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98013219 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96069109 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.95531473 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94785543 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94009868 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92193062 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91586874 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90196132 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89693318 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89249092 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89055581 |
| 64 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88791282 |
| 65 | Axon guidance_Homo sapiens_hsa04360 | 0.88314365 |
| 66 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.87784788 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87660313 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86773377 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83619990 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82686358 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82511428 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82071853 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.81342212 |
| 74 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80421817 |
| 75 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79849086 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79653294 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.79335378 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79033666 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79014968 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77681735 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77332525 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77254090 |
| 83 | * Prostate cancer_Homo sapiens_hsa05215 | 0.76827146 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76768272 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76487745 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74885353 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.74532196 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.73833189 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73602845 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.71670156 |
| 91 | * Hepatitis C_Homo sapiens_hsa05160 | 0.71614598 |
| 92 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71228908 |
| 93 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70976168 |
| 94 | * Focal adhesion_Homo sapiens_hsa04510 | 0.70735132 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.70564168 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69706536 |
| 97 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69666392 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69306138 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68741834 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68152465 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.65312404 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64421416 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64340069 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63764830 |
| 105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62166241 |
| 106 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61004471 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.60419103 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59099304 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59077279 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.59066110 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.58358335 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58205609 |
| 113 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.57926786 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57806300 |
| 115 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57622638 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57539749 |
| 117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57319811 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56970462 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55728139 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53815259 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.53805125 |
| 122 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53226319 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49920978 |
| 124 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49566404 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49196616 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49065939 |
| 127 | * Insulin resistance_Homo sapiens_hsa04931 | 0.48224275 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46749017 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45588276 |
| 130 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45466807 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45334055 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.44638703 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44371326 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43739657 |
| 135 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43254040 |
| 136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42400707 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42078866 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41969689 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40834518 |

